Gossamer Bio Stock Technical Analysis
| GOSS Stock | USD 0.49 -0.02 -3.92% |
As of the 12th of March 2026, Gossamer Bio indicates a price level of 0.49 per share. Price-based signals reflect Standard Deviation of 11.51, risk adjusted performance of -0.09, and Market Risk Adjusted Performance of -0.39. The model quantifies price stability and directional movement. Volatility-adjusted metrics gain importance under $1.00. Relative volatility positioning is benchmarked against peers.
Gossamer Bio Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Gossamer, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to GossamerGossamer Bio's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Gossamer Bio Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 3.69 | Strong Buy | 9 | Odds |
The summary for Gossamer Bio includes current and past analyst recommendations. The view also includes average analyst consensus. The timing of analyst rating changes for Gossamer Bio matters as much as the direction. Rating upgrades issued after a large decline in Gossamer stock may reflect backward-looking analysis, while pre-emptive upgrades ahead of a catalyst tend to have stronger price impact.
Earnings Share -0.69 | Revenue Per Share | Quarterly Revenue Growth 0.402 | Return On Assets | Return On Equity |
Investors evaluate Gossamer Bio using market value and book value, each describing different facets of the business. Gossamer Bio's market capitalization is 117.37 M. A P/B ratio of 2.66 indicates the market values Gossamer Bio above its accounting book value. Enterprise value stands at 151.57 M. Intrinsic value represents an estimate of underlying worth and can differ from both market price and book value. Valuation methods compare these perspectives to frame context.
Value and price for Gossamer Bio are related but not identical, and they can diverge across cycles. For Gossamer Bio, key inputs include a P/B ratio of 2.66, ROE of -7.83%, and revenue of 114.7 M. Market price reflects the current exchange level formed by active bids and offers.
Gossamer Bio 'What if' Analysis
Running a what-if backtest on Gossamer Bio gives investors a practical way to test how changes in horizon, position size, or market timing might have affected the result. Used properly, this review helps investors decide whether Gossamer Bio's historical reward profile was stable enough to support the current thesis.
| 12/12/2025 |
| 03/12/2026 |
A 0.00 position in Gossamer Bio initiated on December 12, 2025 and held to today would record 0.00 in total gains. That corresponds to a 0.0% cumulative return in Gossamer Bio overall over 90 days. Gossamer Bio competes with or is related to Kalvista Pharmaceuticals, 4D Molecular, Olema Pharmaceuticals, Ventyx Biosciences, Lexicon Pharmaceuticals, Rigel Pharmaceuticals, and Prothena Plc. Peer context helps frame relative positioning. Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and comme... More
Momentum Range Indicators for Gossamer Bio Overview
Upside/downside measures for Gossamer Bio frame directional pressure and range behavior. They compare current price to recent trend and sentiment readings.
| Information Ratio | -0.13 | |||
| Maximum Drawdown | 89.87 | |||
| Value At Risk | -9.52 | |||
| Potential Upside | 9.3 |
Volatility and Risk Indicators for Gossamer Bio Overview
These indicators track Gossamer Bio's volatility and return range dynamics. The metrics rely on historical prices to describe variability over time.| Risk Adjusted Performance | -0.09 | |||
| Jensen Alpha | -1.42 | |||
| Total Risk Alpha | -1.18 | |||
| Treynor Ratio | -0.40 |
Mean reversion in Gossamer Bio is more reliable over longer time horizons. Short-term deviations can persist and even widen before correcting, making position sizing and risk management critical.
Gossamer Bio Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | -0.09 | |||
| Market Risk Adjusted Performance | -0.39 | |||
| Mean Deviation | 5.7 | |||
| Coefficient Of Variation | -775.83 | |||
| Standard Deviation | 11.51 | |||
| Variance | 132.53 | |||
| Information Ratio | -0.13 | |||
| Jensen Alpha | -1.42 | |||
| Total Risk Alpha | -1.18 | |||
| Treynor Ratio | -0.40 | |||
| Maximum Drawdown | 89.87 | |||
| Value At Risk | -9.52 | |||
| Potential Upside | 9.3 | |||
| Skewness | -4.87 | |||
| Kurtosis | 34.39 |
Gossamer Bio Backtested Returns
Gossamer Bio posts a severely unstable volatility profile during the defined timeframe. It shows an Efficiency (Sharpe) Ratio of -0.15, quantifying negative return efficiency across 3 months. Signal processing identified twenty-three dispersion-based indicators. Please review metrics such as standard deviation of 11.51, risk-adjusted performance of -0.09, and market risk-adjusted performance of -0.39 to examine volatility dispersion. The firm maintains a market beta of 3.77, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Gossamer Bio will likely underperform. At this point, Gossamer Bio has a negative expected return of -1.77%. Please make sure to verify Gossamer Bio's relationship between the Accumulation Distribution and period momentum indicator, to decide if Gossamer Bio's performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.69 |
Good predictability
Gossamer Bio exhibits good predictability. Autocorrelation measures the degree of predictability between Gossamer Bio time series from 12th of December 2025 to 26th of January 2026 and from 26th of January 2026 to 12th of March 2026. The stronger the relationship between the current interval and its lagged values, the more accurately future price behavior of Gossamer Bio may be projected. A serial correlation of 0.69 indicates that around 69.0% of current Gossamer Bio price fluctuations can be explained by its historical price movements.
| Correlation Coefficient | 0.69 | |
| Spearman Rank Test | 0.74 | |
| Residual Average | 0.0 | |
| Price Variance | 0.85 |
Technical analysis for Gossamer Bio evaluates price and volume patterns over time. Typical tools include moving averages, relative strength index, regressions, and price correlations.
Gossamer Bio Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Gossamer Bio volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Gossamer Bio Technical Analysis
Technical analysis of Gossamer Bio evaluates price structure, momentum, and volatility clustering. Technical signals complement fundamental exposure context. Gossamer Bio has a market cap of 117.37 M, ROE of -7.83%. 
Rifka Kats · Member of Macroaxis Editorial Board
Unless otherwise specified, financial data for Gossamer Bio is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Updates may occur throughout the day.
Gossamer Stock is Curated By:
Rifka Kats · Member of Macroaxis Editorial BoardGossamer Bio Technical Indicators
A technical review of Gossamer Bio can improve timing discipline by comparing momentum, reversal risk, and confirmation signals across several time horizons. The stronger process confirms one signal with others instead of reacting to one pattern in isolation.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | -0.09 | |||
| Market Risk Adjusted Performance | -0.39 | |||
| Mean Deviation | 5.7 | |||
| Coefficient Of Variation | -775.83 | |||
| Standard Deviation | 11.51 | |||
| Variance | 132.53 | |||
| Information Ratio | -0.13 | |||
| Jensen Alpha | -1.42 | |||
| Total Risk Alpha | -1.18 | |||
| Treynor Ratio | -0.40 | |||
| Maximum Drawdown | 89.87 | |||
| Value At Risk | -9.52 | |||
| Potential Upside | 9.3 | |||
| Skewness | -4.87 | |||
| Kurtosis | 34.39 |
Gossamer Bio March 12, 2026 Daily Trend Indicators
A technical review of Gossamer Bio can improve timing discipline by comparing momentum, reversal risk, and confirmation signals across several time horizons. The stronger process confirms one signal with others instead of reacting to one pattern in isolation.
| Accumulation Distribution | 466,841 | ||
| Daily Balance Of Power | -0.67 | ||
| Rate Of Daily Change | 0.96 | ||
| Day Median Price | 0.51 | ||
| Day Typical Price | 0.50 | ||
| Price Action Indicator | -0.03 |
Additional Tools for Gossamer Stock Analysis
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |